Lunsumio Velo
NDC 50242-201, Mosunetuzumab, injection, from Genentech, Inc..
- Product NDC
- 50242-201
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761263
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MOSUNETUZUMAB45 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-201-01 | 50242020101 | 1 VIAL, GLASS in 1 CARTON (50242-201-01) / 1 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6a2b6dc2-48bd-4da7-a611-bc6bae2893c8Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-201
Use it
Look up 50242-201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.